Skip to main content
. 2019 Sep 19;8(2):167–174. doi: 10.1177/2050640619878974

Figure 3.

Figure 3.

(a) Adalimumab therapy retention among the total study cohort (n = 44). (b) Adalimumab therapy retention among patients with terminal ileum (TI) wall thickness lower versus higher than 4 mm (p = 0.03). Blue line: patients with TI thickness below 4 mm. Green line: patients with TI thickness above 4 mm. (c) Adalimumab therapy retention among patients with colonic wall thickness below versus above 5 mm (p = 0.1). Blue line: patients with colonic wall thickness below 5 mm. Green line: patients with colonic wall thickness above 5 mm.